Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients.
about
Yin Yang gene expression ratio signature for lung cancer prognosisLung Cancer Gene Signatures and Clinical PerspectivesMolecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesotheliomaA pathway-based data integration framework for prediction of disease progressionPrognostic factors in resected lung carcinomas.Development and validation of a prognostic gene-expression signature for lung adenocarcinomaSPARCoC: a new framework for molecular pattern discovery and cancer gene identificationImproving the pathologic evaluation of lung cancer resection specimens.Time-dependent ROC curve analysis in medical research: current methods and applications.Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancerIdentification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine.A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis.Hidden treasures in "ancient" microarrays: gene-expression portrays biology and potential resistance pathways of major lung cancer subtypes and normal tissue.SNRFCB: sub-network based random forest classifier for predicting chemotherapy benefit on survival for cancer treatment.Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer.High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusion.
P2860
Q28385778-BE2A3958-29ED-4794-9FC7-F5D6DA233959Q28387769-1FF9AA9E-FCDF-4FC2-992B-095DAD6C97C4Q28482133-31ADC131-0306-4244-B3B1-5BEA09413FE9Q30574210-0417D4C6-1A71-4290-A0CF-776B879A80E2Q33697964-987116CB-C8C7-45BD-AE93-F83547A228D8Q34412292-80595197-BF50-48AB-BB0F-9DE5F6EF72B5Q35175659-50C197D0-F8D4-434C-98C0-55244BBDBBB2Q35996033-C31F9AEA-7C89-43EE-BE68-599A7A430B4EQ36340398-37F60C24-9428-4B53-BB50-DE602A52F5FCQ36844877-CCBB3E7A-162A-4913-B17B-A418ABF18DD8Q37499268-5ED4FBFF-2F5C-4F18-9EA9-94F3732900B4Q37716461-7B8F96DE-FCC4-40D6-942A-569BA07A2768Q38107464-596987A5-58A5-4A74-B3B8-D8CF44037D7FQ38471484-F4E43A8D-3C59-41E4-96F0-A702FCAA642FQ40007032-14FFEFC5-17F9-4A54-A8F1-98563698AA37Q40646057-9208D0B9-9905-42EA-8C1B-8C899F93162DQ55332886-AAC02674-5126-4EE3-877B-9659CA6CE9D3
P2860
Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Gene-expression signature pred ...... all cell lung cancer patients.
@ast
Gene-expression signature pred ...... all cell lung cancer patients.
@en
Gene-expression signature pred ...... all cell lung cancer patients.
@nl
type
label
Gene-expression signature pred ...... all cell lung cancer patients.
@ast
Gene-expression signature pred ...... all cell lung cancer patients.
@en
Gene-expression signature pred ...... all cell lung cancer patients.
@nl
prefLabel
Gene-expression signature pred ...... all cell lung cancer patients.
@ast
Gene-expression signature pred ...... all cell lung cancer patients.
@en
Gene-expression signature pred ...... all cell lung cancer patients.
@nl
P2093
P2860
P1433
P1476
Gene-expression signature pred ...... all cell lung cancer patients.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0030880
P407
P577
2012-01-23T00:00:00Z